Skip to main content

Biosceptre expression and purification strategy (BIF)

Project Member(s): Ralph, P.

Funding or Partner Organisation: Biosceptre (Aust) Pty Ltd (Biosceptre (Australia) Pty Ltd)
Biosceptre (Aust) Pty Ltd (Biosceptre (Australia) Pty Ltd)

Start year: 2022

Summary: Continuation of expression and purification strategy to prepare a panel of tumour antigen specific adaptor molecules (TASAMs) for the novel and universal adaptor CAR-T system (UAdCAR)

FOR Codes: Human pharmaceutical treatments , Medical molecular engineering of nucleic acids and proteins